BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33677106)

  • 1. Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway.
    Shah K; Panchal S; Patel B
    Pharmacol Res; 2021 May; 167():105532. PubMed ID: 33677106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974.
    Liu J; Pan S; Hsieh MH; Ng N; Sun F; Wang T; Kasibhatla S; Schuller AG; Li AG; Cheng D; Li J; Tompkins C; Pferdekamper A; Steffy A; Cheng J; Kowal C; Phung V; Guo G; Wang Y; Graham MP; Flynn S; Brenner JC; Li C; Villarroel MC; Schultz PG; Wu X; McNamara P; Sellers WR; Petruzzelli L; Boral AL; Seidel HM; McLaughlin ME; Che J; Carey TE; Vanasse G; Harris JL
    Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20224-9. PubMed ID: 24277854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of the linkage elements of porcupine antagonists led to potent Wnt signaling pathway inhibitors.
    Dong Y; Li K; Xu Z; Ma H; Zheng J; Hu Z; He S; Wu Y; Sun Z; Luo L; Li J; Zhang H; Zhang X
    Bioorg Med Chem; 2015 Nov; 23(21):6855-68. PubMed ID: 26455655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma.
    Li J; Wu G; Xu Y; Li J; Ruan N; Chen Y; Zhang Q; Xia Q
    Biomed Res Int; 2020; 2020():2527643. PubMed ID: 32104684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical Modulation of WNT Signaling in Cancer.
    Zhang LS; Lum L
    Prog Mol Biol Transl Sci; 2018 Jan; 153():245-269. PubMed ID: 29389519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porcupine inhibitor LGK‑974 inhibits Wnt/β‑catenin signaling and modifies tumor‑associated macrophages resulting in inhibition of the malignant behaviors of non‑small cell lung cancer cells.
    Tang Y; Jiang M; Chen A; Qu W; Han X; Zuo J; Xu G; Song Y; Chen C; Ke X
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34080032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms and inhibition of Porcupine-mediated Wnt acylation.
    Liu Y; Qi X; Donnelly L; Elghobashi-Meinhardt N; Long T; Zhou RW; Sun Y; Wang B; Li X
    Nature; 2022 Jul; 607(7920):816-822. PubMed ID: 35831507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade to pathological remodeling of infarcted heart tissue using a porcupine antagonist.
    Moon J; Zhou H; Zhang LS; Tan W; Liu Y; Zhang S; Morlock LK; Bao X; Palecek SP; Feng JQ; Williams NS; Amatruda JF; Olson EN; Bassel-Duby R; Lum L
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1649-1654. PubMed ID: 28143939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell biology. The unusual case of Porcupine.
    Lum L; Clevers H
    Science; 2012 Aug; 337(6097):922-3. PubMed ID: 22923569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel porcupine inhibitor blocks WNT pathways and attenuates cardiac hypertrophy.
    Jiang J; Lan C; Li L; Yang D; Xia X; Liao Q; Fu W; Chen X; An S; Wang WE; Zeng C
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3459-3467. PubMed ID: 30076960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porcupine inhibitors impair trabecular and cortical bone mass and strength in mice.
    Funck-Brentano T; Nilsson KH; Brommage R; Henning P; Lerner UH; Koskela A; Tuukkanen J; Cohen-Solal M; Movérare-Skrtic S; Ohlsson C
    J Endocrinol; 2018 Jul; 238(1):13-23. PubMed ID: 29720540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverse chemical scaffolds support direct inhibition of the membrane-bound O-acyltransferase porcupine.
    Dodge ME; Moon J; Tuladhar R; Lu J; Jacob LS; Zhang LS; Shi H; Wang X; Moro E; Mongera A; Argenton F; Karner CM; Carroll TJ; Chen C; Amatruda JF; Lum L
    J Biol Chem; 2012 Jun; 287(27):23246-54. PubMed ID: 22593577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells.
    Kleszcz R; Szymańska A; Krajka-Kuźniak V; Baer-Dubowska W; Paluszczak J
    Cell Oncol (Dordr); 2019 Aug; 42(4):505-520. PubMed ID: 31089983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental inhibition of porcupine-mediated Wnt O-acylation attenuates kidney fibrosis.
    Madan B; Patel MB; Zhang J; Bunte RM; Rudemiller NP; Griffiths R; Virshup DM; Crowley SD
    Kidney Int; 2016 May; 89(5):1062-1074. PubMed ID: 27083283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WNT ligands control initiation and progression of human papillomavirus-driven squamous cell carcinoma.
    Zimmerli D; Cecconi V; Valenta T; Hausmann G; Cantù C; Restivo G; Hafner J; Basler K; van den Broek M
    Oncogene; 2018 Jul; 37(27):3753-3762. PubMed ID: 29662191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on the role of Wnt biology in cancer.
    Mirabelli CK; Nusse R; Tuveson DA; Williams BO
    Sci Signal; 2019 Jul; 12(589):. PubMed ID: 31289213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effect of a novel Wnt pathway inhibitor on cardiac regeneration after myocardial infarction.
    Yang D; Fu W; Li L; Xia X; Liao Q; Yue R; Chen H; Chen X; An S; Zeng C; Wang WE
    Clin Sci (Lond); 2017 Dec; 131(24):2919-2932. PubMed ID: 29162747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of the Porcupine Inhibitor WNT974 in Mice.
    Zhang LS; Lum L
    Methods Mol Biol; 2016; 1481():111-7. PubMed ID: 27590157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and evaluation of potent Wnt signaling inhibitors featuring a fused 3-ring system.
    Xu Z; Li J; Wu Y; Sun Z; Luo L; Hu Z; He S; Zheng J; Zhang H; Zhang X
    Eur J Med Chem; 2016 Jan; 108():154-165. PubMed ID: 26647303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An
    Asciolla JJ; Miele MM; Hendrickson RC; Resh MD
    J Biol Chem; 2017 Aug; 292(33):13507-13513. PubMed ID: 28655768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.